5 September - Lumina Retina

09:00 - 09:10

WELCOME DELEGATES

Kıvanç Güngör, TOD President; Micha Nussbaum, Roche

RETINAL THERAPIES - FOUNDATIONS AND FUTURE

CHAIR Sibel Kadayıfçılar, Türkiye

09:10 - 09:25

Evolution of Retinal Therapies

PRESENTER Nirojini Sivachandran, Canada

09:25 - 09:40

Translating Dual Pathways: From Discovery to Clinical Practice Innovation

PRESENTER SriniVas Sadda, US

09:40 - 09:55

Panel discussion

All Speakers

09:55 - 10:15

BREAK

[SATELLITE SYMPOSIUM] The Role of Faricimab in the Treatment of Retinal Diseases

10:15 - 10:20

Opening Remarks

PRESENTER SriniVas Sadda, US

10:20 - 10:40

The nAMD Evidence Arena

PRESENTER Sibel Demirel, Türkiye

10:40 - 11:00

The DME Evidence Arena

PRESENTER Nirojini Sivachandran, Canada

11:00 - 11:15

The PCV Evidence Arena

PRESENTER Colin Tan, Singapore

11:15 - 11:25

Panel Discussion

Manoj Khatri & Soumen Mondal, India

11:25 - 11:30

Closing Remarks

11:30 - 11:50

BREAK

11:50 - 12:40

Real World Data with Real World Discussions

CHAIR Ali Osman Saatci, Türkiye

(15 min) Colin Tan – VOYAGER, FARETINA, FARWIDE
(10 min) Akın Çakır – Türkiye's Independent RWE: FARTURK
(10 min) Manoj Khatri – India's Independent RWE
Panel Discussion (15 min)

12:40 - 13:45

LUNCH

REAL WORLD EXPERIENCES (CASE STUDIES)

CHAIR Figen Şermet, Türkiye

13:45 - 15:15

nAMD & PCV (45 min)

PRESENTERS Soumen Mondal, India; Mehmet Ali Şekeroğlu, Türkiye; Hina Khan, Pakistan; Jana Nivichka Kjaeva, Macedonia

13:45 - 15:15

DME & RVO (45 min)

PRESENTERS Marina Arkhipova, Russia; Mehmet Numan Alp, Türkiye; Rinat Faizrakhmanov, Russia; Mentor Gorani, Kosovo

15:15 - 15:30

BREAK

15:30 - 15:45

Looking to the Future

CHAIR Bora Eldem, Türkiye

PRESENTER Stefan Scheidl, Roche

15:45 - 16:00

The impact of targeting new pathway: capacity & service utilisation

CHAIR Bora Eldem, Türkiye

PRESENTER Nirojini Sivachandran, Canada

16:00 - 16:15

Discussion & Clossing Remarks

All Speakers

19:30 - 22:00

GALA DINNER

LUMINA RETINA

Agenda